Research and Markets, the largest resource for market research information in world providing essential market research reports, industry research, industry analysis, forecasts, market studies, company profiles and country reports.
Welcome - Register - Login - Help/FAQ - 0 items View Basket
Worlds Largest Market Research Resource - 1516232 Live Reports
Search Research and Markets
  Search
Enter keywords, a title or
a report id number below.





Advanced   
Company search
Register for free email updates of market research
Currency
  Select a currency for use throughout the site



Viewing report

Order by Fax
Ask a Question
Printer Friendly
PDF Brochure
Site LicenseAdd to Basket
EnterprisewideAdd to Basket
Electronic (PDF)Add to Basket
Live Chat Live Help Software for Website

C. R. Bard, Inc. (BCR) - Financial and Strategic SWOT Analysis Review

GlobalData, March 2012, Pages: 52


  Description  
   Table of Contents   
   Companies Mentioned   
    
    
     
  Enquire before Buying   
  Send to a Friend   

C. R. Bard, Inc. (BCR) - Financial and Strategic SWOT Analysis Review

Summary

C. R. Bard, Inc. (Bard) is a multinational medical device company. It carries out the design, manufacture, packaging, distribution and sale of medical, surgical, diagnostic and patient care devices. It offers life-enhancing medical technologies in the areas of Vascular, Urology, Oncology and Surgical Specialty products. The company offers its wide range of products to hospitals, individual health care professionals, extended care facilities, and alternate site facilities. The company conducts its operations across Americas, Europe, Asia pacific, the Middle East and Africa. It has international manufacturing facilities in Puerto Rico, Germany, France, Belgium, Mexico and Malaysia. Bard is headquartered in New Jersey, the US.


The company seeks to build its position in the marketplace through internal development, partnerships, strategic alliances and acquisition of complementary businesses, technologies and products. As part of its strategy, Bard recently acquired Lutonix, Inc., Medivance, Inc., and ClearStream Technologies Group plc.

C. R. Bard, Inc. Key Recent Developments

Mar 01, 2012: Hospitals, Healthcare Providers To Benefit From New Premier Agreements For Invasive Cardiology Equipment
Jan 31, 2012: Bard Reports Revenue Of $2.9 Billion In 2011
Dec 20, 2011: C. R. Bard Provides Updates On Pipeline Products At Annual Investor Conference
Nov 14, 2011: Hospitals, Healthcare Providers To Benefit From New Premier Agreements For Electrophysiology Products
Oct 25, 2011: Bard Reports Revenues Of $719.2m In Q3 2011

This comprehensive SWOT profile of C. R. Bard, Inc. provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Key manufacturing facilities – A list of key manufacturing facilities of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Note: Some sections may be missing if data is unavailable for the company.

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.



Customers who bought this item also bought

Bard Medical Device Company Intelligence Report

C. R. Bard, Inc. Market Share Analysis

C.R. Bard, Inc. Market Share Analysis

LeMaitre Vascular, Inc. (LMAT) - Financial and Strategic SWOT Analysis Review

Barr Pharmaceuticals Generics Company Intelligence Report

Covidien plc (COV) - Financial and Strategic SWOT Analysis Review

C. R. Bard, Inc. (BCR) - Product Pipeline Analysis

Abbott Laboratories (ABT) - Financial and Strategic SWOT Analysis Review

Ethicon, Inc. - Strategic SWOT Analysis Review

C. R. Bard, Inc. Strategic Analysis Profile



For enquiries please call us on:
  +353-1-415-1241 (GMT Office Hours)
  1-800-526-8630 (US/Canada Toll Free)
  1-917-300-0470 (EST Office Hours)

   All rights reserved. © Copyright 2012 Research and Markets
   Terms and conditions Privacy Policy Publishers Employment Opportunities Site Map Link to us Webmaster Affiliate Network


Research and Markets RSS Feeds